Alzheimer’s Research: Space Experiment Breakthrough
- An international team of scientists has successfully determined the high-resolution structures of amyloid β (Aβ40) fibrils,which carry the Tottori-type familial mutation (D7N).
- The D7N mutation, found in the N-terminal region of the Aβ peptide, is linked to rare familial Alzheimer's cases in Japan.
- On Earth, this variant typically forms amorphous, non-fibrillar aggregates, hindering structural analysis.
Scientists achieved a major breakthrough in Alzheimer’s research, unlocking high-resolution structures of amyloid fibrils thanks to a space-based experiment. This groundbreaking study, conducted on the International Space Station, focused on the Tottori-type familial mutation (D7N) of amyloid β (Aβ40), providing critical insights into this devastating disease. The microgravity environment facilitated the formation of well-ordered fibrils, overcoming limitations of Earth-based analysis. the research revealed how the D7N mutation disrupts stabilizing interactions, perhaps fueling disease progression and represents a leap for structural biology in space. Learn how this experiment paves the way for innovative insights; News Directory 3 offers more science updates.Discover what’s next for Alzheimer’s research and potential treatments.
Space-Based Experiment Opens New Avenues in Alzheimer’s Research
Updated June 25,2025
An international team of scientists has successfully determined the high-resolution structures of amyloid β (Aβ40) fibrils,which carry the Tottori-type familial mutation (D7N). The research, conducted aboard the International Space Station’s “kibo” module, provides new insights into Alzheimer’s disease.Their findings were published in ACS Chemical Neuroscience.
The D7N mutation, found in the N-terminal region of the Aβ peptide, is linked to rare familial Alzheimer’s cases in Japan. Researchers from the Exploratory Research Centre on Life and Living systems (ExCELLS), national Institutes of Natural Sciences, Nagoya City University, Nagoya University, Japan Aerospace Exploration Agency (JAXA), and Japan Space Forum collaborated on the project.
On Earth, this variant typically forms amorphous, non-fibrillar aggregates, hindering structural analysis. However,the microgravity environment aboard the ISS considerably reduced these aggregates,allowing the formation of well-ordered fibrils suitable for cryo-electron microscopy structural analysis.
The structural data revealed that the D7N mutation disrupts stabilizing interactions at the N-terminus, possibly promoting alternative aggregation pathways relevant to the progression of Alzheimer’s disease. The team said microgravity offers an ideal environment for studying the self-assembly behavior of amyloidogenic proteins by eliminating convection and sedimentation.
The study demonstrates the potential of structural biology in space to overcome limitations of Earth-based experiments, advancing the understanding of Alzheimer’s disease mechanisms.
What’s next
Researchers plan to continue using space-based experiments to investigate othre aspects of Alzheimer’s disease and related neurological disorders, potentially leading to new therapeutic targets.